EPHB2, His, Human
| ¥2600 | |
| Z05254-100 | |
|
|
|
|
|
|
|
|
|
| ¥2600 | |
| Z05254-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 59.2 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized EPHB2, His, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human Ephrin-B2, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA. »
Immobilized EPHB2, His, Human at 0.5 μg/ml(100 μl/well) on the plate. Dose response curve for Anti-EPHB2 Antibody, hFc Tag with the EC50 of 9.0ng/ml determined by ELISA. »
The purity of EPHB2, His, Human is greater than 95% as determined by SEC-HPLC. »
EPHB2, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
EPHB2, His, Human, hFc Tag captured on CM5 Chip via Protein A can bind Human EPHB2, His Tag with an affinity constant of 82.97 pM as determined in SPR assay (Biacore T200). »
| Target Background | EphB2, a receptor tyrosine kinase for ephrin ligands, is overexpressed in various cancers and plays an important role in tumor progression. EPHB2 promotes endothelial-mesenchymal transition (EMT) and elicits associated pathologic characteristics of glioblastoma multiforme (GBM) such as invasion and migration. EPHB2 is epigenetically overexpressed in hypoxia, a condition highly prevalent in malignancy. Furthermore, HIF-2α is required for EPHB2 stabilization by hypoxia. |
| Synonyms | DRT; ERK; HEK5; TYRO5; CAPB; EK5; EPHT3; PCBC; Cek5; EphB2; EPHT3MGC87492; Nuk; Qek2; Sek3 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.